In June 2021, after discovering a potential health risk related to the foam in certain CPAP, BiPAP and Mechanical Ventilator devices, Philips Respironics issued a voluntary Field Safety Notice (outside U.S.) / voluntary recall notification (U.S. only). We are focused on delivering the best care possible, while supporting patients, customers and clinicians throughout the remediation process.
Globally, we have remediated 99% of actionable* sleep therapy device registrations to date.
As the remediation of the ventilator devices continues, Philips Respironics will be communicating with Durable Medical Equipment providers (DMEs) directly throughout the process. If you are a patient or caregiver with an affected Philips Respironics ventilation device, you do not need to take any action. All ventilation remediation will be handled via your DME.
*Actionable registrations are those that contain the necessary information needed to complete the remediation and are not awaiting further information.
* This is a voluntary recall notification in the US and field safety notice in other countries
April 4, 2024
You are about to visit a Philips global content page
Continue